BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Nov 12, 2026, 4:09 PM IST
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 29.87 million as of November 12, 2026. It is the 41,716th most valuable company in the world and the 438th biggest in Israel. Its market cap has decreased by 39.79% in one year.
Market Cap
29.87M
Enterprise Value
23.05M
Revenue
4.15M
Global Rank
Country Rank
#438 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 29.87M, an increase of 18,221.91%. That is a compound annual growth rate of 30.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 29.87M | -28.50% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 179.89M |
| Matricelf | 81.08M |
| Clal Biotechnology Industries | 33.72M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 27.15M |
| Evogene | 17.38M |
| XTL Biopharmaceuticals | 17.22M |
| Can-Fite BioPharma | 15.85M |